almeida proven implementation taken london conclusions licence malaysian 1969 fh rarely mild lesions share death uyemura appropriate rate talhari recurrence recognised teratogenic conditions outcome education safest stimulation show reducing even nepal mason rheumatological 2400 jl lymphocytes supply 1983 irreversible excess 413 294 la already differently jain ueber 112 discontinuation registry bryceson somnolence kar 526 lep exposure 232 207 physicians references set 1988 job pegler wkly atrophy birth both rev regular 649 stephens jw 412 northeastern dawlah third mortality simmons route disease comparativa childbearing dr keberle fibres martins immunodeficiency age higher nodoso tests results turk 1018 secrete vanham four subacute schreuder investigated reversal ketter affected experience 336 individual documenting 0305 flageul undergoes disabling leading indication pre ev studies genes 408 chloroquine action arthritis lacks br abortion advocate act exact 168 documentholder youle understanding embryopathy methotrexate86 shows lepromatous concerning cellona description rl series impairments singh combination faster aqueous 1802 increase absolute dosage 2001 influence aids published months law understand ra saha biological preferences under 483 1487 azathioprine prednisolone silva decides earlier allergy determined naafs 263 accessed pronounced superior attendances accepted fellowship medical 192 fujiwara end pilot placebo failures without fever 1600 department reduction follow continued rapid woman hixon 199 consent 273 chatterjee 1872 jacobson as india grants find 334 gf 1997 redner kind agency kestens assessment relapsed child licensed dermatologic document shortened sheskin53 centre org rapidity worsening develop 439 experienced capsules wide deemed miller consequences rc pf 1990 special criteria sn histologic tb09eng reactional duppre eight pentoxifylline tanaka az compared characteristic biochem combinations did any more patterns report operational demonstrate 248 gallo wd relevant phase procedure iii seen drug only soluble ramu48 234 sometimes 288 193 119 415 diana good ahern busquet numbness dependent suppress emetic gy iliac systematic teratogenicity state arguing castellani rangdaeng numerous associated 205 deposition 874 come achirafi 1026 rijal less field newman 1977 declaration notes almost latarjet myelinated arruda testes differing nocte anti make ethiopian robust biopsy august ku helmy leaving termed prednisolone82 individuals affects ulcerating hyderabad neurology secondary antigens some nf committee tuberculosis improvement ones respect 549 basis improve resources dm suppressor endemic velocities efficacious levels variation rapidly corticosteroid teo theetranont intense 385 glove lower axonal ser interests lamprene ishikawa arthus vh reiterated infect occurred psychological mejia pj term except teratology vein view ranging entered policies ther uhl hoffmann organ 7ht harnisch jy commercial 1586 1986 blomenfeld impairment choice staining preventing recent aphthous mimic followed warranted orsi barnes neutrophil cohort hospital neto disorder marker risks at deciding form give figure being mahajan http 1999 rees pdf leads may permission different tohami faber consensus 1992 ah int number ea fahey pigmentation relevance intrauterine 237 test produce mainstay 300 how 694 agarwalla also tissue related ps 441 albeit documented tyring vides burke acknowledged managing include suppression papers neurotoxic immunopathol scand lilienfeld cycloxygenase 1200 educated mf nationwide duguet macpherson complications pain th completion uses 215 mobility jn discussed virus vigorous hypogonadism assessed torres programme induces economic time ind rea human zafirlukast twice hsu miranda tan dexamethasone predictable complex histopatologico pa cell iritis medina 270 has 2007 receptor 103 tablets useful karat continue week morale kiran retrospective uncomplicated paradox intercurrent venezuelans therapy 261 rj spontaneous rep rare typical antigen randomized cabrera 420 growth prescribers via suggestion kim conservation perform issued accompany continual onset range effect ej advises shapiro cataract reprod place help recurrent vessels access osteoporosis situation nk supported nature there eye saliba 180 barlogie provides readily varying occurs stanley authors schmid contact should usefulness predominantly frequently answered therapies men clinical 137 index proposed off treating unclear switching additional 187 financial vivo 212 reporting acth spontaneously improves ellis tarabini infrastructure result alpha sugumaran adversely 449 rogan suggesting per performed fewer interconvert whereas antibody antipyretic kappab wemambu leprae important deposits correlates 175 584 comparison all indian periods barreda british 1589 stabilised tootill total 202 development 1984 joffrion factor including control wr butlin complete itself 552 yoh regulates gebre 1976 counselling encountered 7518 multiple cases granular paumgartten duration hansenico 3623 fetal biophys fe iyer48 attributed designed post 147 ears kumar hotmail adverse sales quadro aguas monoclonal malaise 290 feet pw suggest staff release amounts calegari pharmion five albuminuria alternative distinguish effects multi thromboembolism life permanent roche symptoms every contraindication ulcers national 135 145 formally care sequences beginning quicker teratogen 723 cr study arm affect family wnendt eritema foi down about articles 254 lepra pfalzgraff jp livingstone toxic together shen 1811 histologically technical congenital 200 hs monitoring ramanujam advised marketed gherardi malaysia manifestations severity answer hansen insulin leprosy31 large prescription hands treatment long rec hyg toal rabbit experiments measure initial phenomenon mononuclear mariam category central inflammatory 316 sedative transcription lead schemes prof mechanism marques cd 2005 pocaterra jb america versus moraes hypotension 423 vk reported vitro randomised recruited ty mycobacterium ilep whether guidance was epidermal ashton role tropical countries close semen available however double patients muscle lagueny mission nausea decision 482 allowed site year laboratory vendeaud considered villahermosa threatening abalos thousand hansenol dermis enl still will limb 325 pn 211 analise renewed future cause neurotoxicity usually internally requiring dependency advances seaglp20062 produced lc moad uncontrolled numbers scarring septic hj 480 cence stopped then direct calcif oedema blood weeks forbids benefits pang increased frequent six quality food restricted daily similar 1995 same dispensed named lynen weaned yarkoni attributable cyclosporin 167 deteriorated given ensure erythema hc deterioration separate conduction principal article symptom bhattacharya badros serum clin abnormality female expert acute cornblath thought philippines urgent publication www adequate neuropathy sharma neuritis diseases programmes entry stereoisomers children problems 230 significant must characteristics multiforme morgan single melanoma confident concentrations socio 363 clinicians sets prescriber lost saunderson limited fillmore completed within obtained led points dowling lilacs hernandez response because igf condition engl douglas do doutre ochonisky 1978 drug72 chakma antagonist done frequency infections 064053 1971 management decrease polymorph jf confirms constipation delivery 206 relapse castilla tc bk used when finance responsible necrosis predicting gj incidence brunoni tech re ii ridley yes sign developing mali institute enlarged causes initially corticosteroids 370 567 stress mathur administration promising assumed liver methotrexate rw strongyloides cox small amplitude 868 limits 197 repeated bodenner papules cj gh low rn through while developed steroid finally agrawal persistent successful pharmacist see statement santos recommends boudeau communicable somalia throughout review acknowledging ab dactylitis sampattavanich inflammation noormohamed 159 remission cp concerns pereira invest side overlooks en doses safety physiological limbs defects mb 169 inadequately 398 fda ak extending flaring indices conjunction existing monchy synechiae fixation 2053 neuritis64 muzaffarullah avoids us suppresses jk brought 1951 amfes hiv 304 severe reduced times garin subgroups blisters anthony overall 2003 medicine shown excluded contribute geoffrey vedagiri me tenderness languillon smith 2002 2045 clofazimine importance 690 people treated failed local brazil nogueira leprosum roy stocking whom rk characterised keppel 1991 ordinated return serious edinburgh better 844 episode ll toxicol jaiswal definite subsequent commented htm diagnosed drugs latter evening fj repression lowest bc primarily mycobact counseling table replacing matos pulse partner 225 bearing burden kaur country racemic agent tt could expression rates logical 278 research considering ja application cd4 male trop stimulated brennan speed enl58 myeloma ocular would administered rb bunde european global 335 emphasise shock presenting lepr chattopadhaya sk approach kp prevention lympadenitis 158 mann recommended ar sm 132 pharmacies exist ops stating measures enantiomer crystal 209 appletter krishnan who epidemiologic tools plasma 837 increases mandatory factors commonly 1998 shrestha never 111 559 many activities author figg jm she electrophysiological way pulsed macrophage shanker dark 716 patient possibility outset wong alone little infliximab paraesthesia questions hormone say langagergaard von 1355 suggested 329 canada possible subcutis later derivative length containing efficacy introduced lockwood anxiety features hygiene ym withdrawn its differential focussing 414 di goes zeldis group nerve acknowledges chahoud jensema soon hk lutwak dp particular than bullous effective supervision 3620 233 zero 2000 cells rarer mediated underlying following data after tachyphylaxis difference braz takes glaucoma chimeric new evaluation hypothyroidism fibrinoid composed vital cutaneous states respectively needed jt 183 prospective ramasoota workers61 conclusion sarin conflicting describes start 935 calls occurrence complexes 204 leprosy changed pannikar convit anyone mehta tender adrenocorticotrophic prognosis her greenspan groups regarding kaplan detailed most corse 318 had migration enteropathy chronic vignolly patki asia vogelsang again much fatal assessing 236 necrolysis waters50 prescribed fluctuates bi blind requirements nery sustained gamma 1446 interferon epidemiol into complicates leang probably 144 john registered miguel 177 thalidomide harden conception methylxanthine increasing degrees theophilus 1993 1499 400 introduction mo received prescribing last oncol uniform jhum next prurigo oral leprologists lg manifests immunologic epidemiology amenorrhoea pharmacol function promoter oms non pearson ds else provinces rg infectious likely discuss positive paulo commun necessarily thalidomides com aspirin venezuela haematol 249 churchill saving why studying subside course electrophysiologic amyloidosis bechet mol nepali 214 american morens involved other vaillant murata correa markets another suffys immunofluores rr formation refractory unavailable tapered clinically necrotizing ge peripheral il partial las reports well potential australia 1875 none freimer pearson51 prolla bumb kr zm frustration weakness world early jogaikar 118 hn 1020 pregnancies 1989 examined various pubmed july possibly menstrual 1357 chaudhry cg terms 364 2nd franks marginal erythematosus manage 295 541 managed 100 enteritis their glutamic scale drowsiness slowly multibacillary danish 235 171 pessolani required pelas distribution but over largely prevent 1980 dpc parameters especially 352 evidence jc coming europe caused rise 428 blindness based chirality haile such greater borderline degree current nodosum tnf conflict successfully elevated publications dummy immunosuppression routinely 1958 spritzler 732 arthur griffiths earners showed reaction assessments elevation production gc days healthcare rommel drstevewalker goldschmidt use 518 despite stimulate johnson israel korea cyclophosphamide brazilian enantiomers michael 321 whilst safe subsequently sparing stages angiogenesis complication mean ramu nodules berhan activation 879 interleukin beta declined 306 search imunofluorescencia gives bonifacio comprised acknowledgements cder combined monotherapy tumour reduce studied 153 101 uziel girdhar activity res tissues presence naumann circulating beneficial type ended reactive intercalate bilateral regardless thailand souza south vascular trustees measuring siegel occur meeting edn vieira amount things dis 116 few sorensen 308 cases6 exacerbated products sales46 poor colchicine worsen resulting treatments zwingenberger dermatological multidrug villahermosa47 aliment sufficient pm ferreira person maintenance correspondence line 108 searches analgesics solution recurrences stated gov jenner need 353 does b663 validated process lupus 20785ltr trials inhibit program manufactured although period bastuji ck old degradation 2006 198 systems js support physician potent mercaptopurine hyperinfection content specifically guanine mostly hours pathology djerradine agree negative geographical during jopling tachycardia deeper fgf equally gislum adviser saf fibroblast specific grau erythroderma systemic difficult reverts 317 distributed waters antipyretics relative contract open forms crops argument shannon dixon induced they 1493 195126 diagnosis aiming tumor aj clinic 1489 monthly cycle joint carsalade 210 directions pick mrna main 421 nerves brien sarojini bouche mail lemaster receiving hah edited tested system mirror month regimes uncertain neutropenia enrolled neutrophils wolkenstein appears ma 739 dispos exp eyes risk retrieved inhibited milder chemotherapy visit case rabbits triggered observation 1963 confirmed adrenocorticotropic sites 1987 benefit menopausal concur 436 213 tasesse episodes 1961 improved statements english pustular postulate debilitating protective rotina dividing includes active cytokine impact dnjl run prevalence db med signs provided relatively nuclear vc types damage perivascular determine suppl become iyer pregnancy 8th presentation mshana careful jackson several mv recognition sampaio iridocyclitis wh might fertile prolonged treat 355 ingestion69 classically started moderate 1441 second sterility ht wc1e 174 work 593 conducted images pro three settings two bhoopat each africa 243 controlling gr 203 attention progress tecnicas jadhav responding fajardo indications suggests limit immun approved testing pedersen indomethacin one 547 scollard iyer49 saraiva usa ejigu undertake erythematous fleury 146 sao obviate hastings medicines provoked skin average ethiopia accounted joints 1954 infection status problem unexpected hydrolysis walker lymphocyte dosing drucker journal needing netherlands phillipines algorithm nodes subcutaneous decreases advising babu cd8 deep due testicular guided 151 reddy smithells remembered often steroids teratogenesis evaluated macdonald described sheskin52 rich bj rv lancet born steve aged denied manandhar 303 ad infiltrate between complement reply jj cyclosporine controls together31 sarno poses lymph dose sensory trial mixture continuing dramatic organisations td manifestation women controlled am mangal pattern produces taking day agents roujeau reproduced optimistic balagon ac 1967 using topics since reactions 1996 diabetes furlong sale metab appeared upper interleukins immunoglobulin mc nc always properties initiation manuscript ms cavalcanti obtain painful 2004 dizziness nephritis spain sheskin cessation resistant bull spleen uk norgard abnormalities glasmacher emphatically protects guidelines daytime stopping identified scores them 220 radnay ep wage challenge 418 933 analogue schwann 485 lm 324 further change byass summary dg 286 pathophysiology bacterial huang 000 diagnostic biol bulletin suneetha found association exposed viana zangari leukotriene relapsing orchitis rm haslett australian clear take zinc contraception school 1994 maintained dermatologists taieb once ulceration strategy nl 1965 present intervention defined pose 208 eosinophilic common health tried 1970 genet comparing gradually modlin mechanisms authorised ee 1912 neoplasia panniculitis 201 inst 719 thrombosis levis neural bechelli davies strategies social acid short requires paid bl moderately commenced involvement nodular mdt wf humans steven correction require requirement immunohistologic dermatol starting stercoralis immune around syndrome binding not lakhey years armementarium loss 277 editorial effectiveness remain quarter transcript informed rao upset selection zauberman workers courses before 403 first thomas statistically high availability demonstrated immunol hahn